Effects of different colloid infusions on ROTEM and Multiplate during elective brain tumour neurosurgery.

N Li, Svajunas Statkevicius, Bogi Asgeirsson, Ulf Schött

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskriftPeer review

254 Nedladdningar (Pure)

Sammanfattning

The European Medicines Agency does not recommend the use of hydroxyethyl starch-based volume replacement solutions in critically ill patients due to an increased risk of renal failure. However, this recommendation is questionable for its perioperative use. Several recent randomised controlled studies do not indicate a risk for renal failure-not even after high-risk surgery. Human albumin is used in our neurointensive care unit as a part of the "Lund concept" of brain injury resuscitation, and albumin has been introduced in elective neurosurgery instead of starch. The aim of our prospective unblinded observational cohort study was to compare the degree of dilutive coagulopathy after albumin and starch intra-operative fluid therapy.
Originalspråkengelska
Artikelnummer9
TidskriftPerioperative Medicine
Volym4
DOI
StatusPublished - 2015

Ämnesklassifikation (UKÄ)

  • Anestesi och intensivvård

Fingeravtryck

Utforska forskningsämnen för ”Effects of different colloid infusions on ROTEM and Multiplate during elective brain tumour neurosurgery.”. Tillsammans bildar de ett unikt fingeravtryck.

Citera det här